Association of TET1 expression with colorectal cancer progression

References

• Bardhan K, Liu K. Epigenetics and colorectal cancer pathogenesis. Cancers (Basel). 2013;5:676–713.
   PubMedGoogle Scholar
• van Engeland M, Derks S, Smits KM, et al. Colorectal cancer epigenetics: complex simplicity. J Clin Oncol. 2011;29:1382–1391.
   PubMed Web of Science ®Google Scholar
• Feinberg AP, Gehrke CW, Kuo KC, et al. Reduced genomic 5-methylcytosine content in human colonic neoplasia. Cancer Res. 1988;48:1159–1161.
   PubMed Web of Science ®Google Scholar
• Yamada Y, Jackson-Grusby L, Linhart H, et al. Opposing effects of DNA hypomethylation on intestinal and liver carcinogenesis. Proc Natl Acad Sci USA. 2005;102:13580–13585.
   PubMed Web of Science ®Google Scholar
• Suzuki K, Suzuki I, Leodolter A, et al. Global DNA demethylation in gastrointestinal cancer is age dependent and precedes genomic damage. Cancer Cell. 2006;9:199–207.
   PubMed Web of Science ®Google Scholar
• van Rijnsoever M, Grieu F, Elsaleh H, et al. Characterisation of colorectal cancers showing hypermethylation at multiple CpG islands. Gut. 2002;51:797–802.
   PubMed Web of Science ®Google Scholar
• Zou XP, Zhang B, Zhang XQ, et al. Promoter hypermethylation of multiple genes in early gastric adenocarcinoma and precancerous lesions. Hum Pathol. 2009;40:1534–1542.
   PubMed Web of Science ®Google Scholar
• Kriaucionis S, Heintz N. The nuclear DNA base 5-hydroxymethylcytosine is present in Purkinje neurons and the brain. Science. 2009;324:929–930.
   PubMed Web of Science ®Google Scholar
• De Smet C, Loriot A. DNA hypomethylation in cancer: epigenetic scars of a neoplastic journey. Epigenetics. 2010;5:206–213.
   PubMed Web of Science ®Google Scholar
• Tahiliani M, Koh KP, Shen Y, et al. Conversion of 5-methylcytosine to 5-hydroxymethylcytosine in mammalian DNA by MLL partner TET1. Science. 2009;324:930–935.
   PubMed Web of Science ®Google Scholar
• He YF, Li BZ, Li Z, et al. Tet-mediated formation of 5-carboxylcytosine and its excision by TDG in mammalian DNA. Science. 2011;333:1303–1307.
   PubMed Web of Science ®Google Scholar
• Ito S, Shen L, Dai Q, et al. Tet proteins can convert 5-methylcytosine to 5-formylcytosine and 5-carboxylcytosine. Science. 2011;333:1300–1303.
   PubMed Web of Science ®Google Scholar
• Yang H, Liu Y, Bai F, et al. Tumor development is associated with decrease of TET gene expression and 5-methylcytosine hydroxylation. Oncogene. 2013;32:663–669.
   PubMed Web of Science ®Google Scholar
• Huang H, Jiang X, Li Z, et al. TET1 plays an essential oncogenic role in MLL-rearranged leukemia. Proc Natl Acad Sci USA. 2013;110:11994–11999.
   PubMed Web of Science ®Google Scholar
• Abdel-Wahab O, Mullally A, Hedvat C, et al. Genetic characterization of TET1, TET2, and TET3 alterations in myeloid malignancies. Blood. 2009;114:144–147.
   PubMed Web of Science ®Google Scholar
• Hsu CH, Peng KL, Kang ML, et al. TET1 suppresses cancer invasion by activating the tissue inhibitors of metalloproteinases. Cell Rep. 2012;2:568–579.
   PubMed Web of Science ®Google Scholar
• Yang L, Yu SJ, Hong Q, et al. Reduced expression of TET1, TET2, TET3 and TDG mRNAs are associated with poor prognosis of patients with early breast cancer. PLoS One. 2015;10:e0133896.
   PubMed Web of Science ®Google Scholar
• Rawluszko-Wieczorek AA, Siera A, Horbacka K, et al. Clinical significance of DNA methylation mRNA levels of TET family members in colorectal cancer. J Cancer Res Clin Oncol. 2015;141:1379–1392.
   PubMed Web of Science ®Google Scholar
• Neri F, Dettori D, Incarnato D, et al. TET1 is a tumour suppressor that inhibits colon cancer growth by derepressing inhibitors of the WNT pathway. Oncogene. 2014;34:4168–4176.
   PubMed Web of Science ®Google Scholar
• Wu BK, Brenner C. Suppression of TET1-dependent DNA demethylation is essential for KRAS-mediated transformation. Cell Rep. 2014;9:1827–1840.
   PubMed Web of Science ®Google Scholar
• Mariani CJ, Vasanthakumar A, Madzo J, et al. TET1-mediated hydroxymethylation facilitates hypoxic gene induction in neuroblastoma. Cell Rep. 2014;7:1343–1352.
   PubMed Web of Science ®Google Scholar
• Tsai YP, Chen HF, Chen SY, et al. TET1 regulates hypoxia-induced epithelial–mesenchymal transition by acting as a co-activator. Genome Biol. 2014;15:513.
   PubMed Web of Science ®Google Scholar
• Chen HF, Wu KJ. Epigenetics, TET proteins, and hypoxia in epithelial–mesenchymal transition and tumorigenesis. Biomedicine (Taipei). 2016;6:1–8.
   PubMedGoogle Scholar
• Yu D, Li Z, Gan M, et al. Decreased expression of dual specificity phosphatase 22 in colorectal cancer and its potential prognostic relevance for stage IV CRC patients. Tumour Biol. 2015;36:8531–8535.
   PubMed Web of Science ®Google Scholar
• Zhu S, Zhang J, Xu F, et al. IGFBP-rP1 suppresses epithelial–mesenchymal transition and metastasis in colorectal cancer. Cell Death Dis. 2015;6:e1695.
   PubMed Web of Science ®Google Scholar
• Wu SC, Zhang Y. Active DNA demethylation: many roads lead to Rome. Nat Rev Mol Cell Biol. 2010;11:607–620.
   PubMed Web of Science ®Google Scholar
• Meng H, Cao Y, Qin J, et al. DNA methylation, its mediators and genome integrity. Int J Biol Sci. 2015;11:604–617.
   PubMed Web of Science ®Google Scholar
• Huang Y, Rao A. Connections between TET proteins and aberrant DNA modification in cancer. Trends Genet. 2014;30:464–474.
   PubMed Web of Science ®Google Scholar
• Xu W, Yang H, Liu Y, et al. Oncometabolite 2-hydroxyglutarate is a competitive inhibitor of α-ketoglutarate-dependent dioxygenases. Cancer Cell. 2011;19:17–30.
   PubMed Web of Science ®Google Scholar
• Yen KE, Bittinger MA, Su SM, et al. Cancer-associated IDH mutations: biomarker and therapeutic opportunities. Oncogene. 2010;29:6409–6417.
   PubMed Web of Science ®Google Scholar
• Lorsbach RB, Moore J, Mathew S, et al. TET1, a member of a novel protein family, is fused to MLL in acute myeloid leukemia containing the t(10;11)(q22;q23). Leukemia. 2003;17:637–641.
   PubMed Web of Science ®Google Scholar
• Vasanthakumar A, Godley LA. 5-hydroxymethylcytosine in cancer: significance in diagnosis and therapy. Cancer Genet. 2015;208:167–177.
   PubMed Web of Science ®Google Scholar
• Hattori M, Yokoyama Y, Hattori T, et al. Global DNA hypomethylation and hypoxia-induced expression of the ten eleven translocation (TET) family, TET1, in scleroderma fibroblasts. Exp Dermatol. 2015;24:841–846.
   PubMed Web of Science ®Google Scholar
• Nagaraju GP, Bramhachari PV, Raghu G, et al. Hypoxia inducible factor-1α: its role in colorectal carcinogenesis and metastasis. Cancer Lett. 2015;366:11–18.
   PubMed Web of Science ®Google Scholar
• Wu MZ, Chen SF, Nieh S, et al. Hypoxia drives breast tumor malignancy through a TET-TNFα-p38-MAPK signaling axis. Cancer Res. 2015;75:3912–3924.
   PubMed Web of Science ®Google Scholar